Abstract. 8-hydroxy-2'-deoxyguanosine (8-OHdG) is one of the main mutagenic modifications induced in DNA by oxidative stress. Elevated levels of 8-OHdG have been regarded as an independent prognostic factor in different types of cancer. Various enzymes, such as human 8-oxoguanine DNA-glycosylase 1 (hOGG1) and glucose-6-phosphate dehydrogenase (G6PD), act as protection against oxidative stress. The low activity of such enzymes has been consistently associated with increased risk of progression in several tumor types. The aim of this study was to investigate whether 8-OHdG, hOGG1 and G6PD expression in tumor tissues might be a predictor of survival in melanoma patients. The expression of 8-OHdG, hOGG1 and G6PD was immunohistochemically investigated in primary cutaneous melanoma and the effect on survival was analyzed. Furthermore, the immunostaining for p53 and survivin was evaluated and the relationship among 8-OHdG, hOGG1, G6PD, p53 and survivin expression was analyzed. Kaplan-Meier analysis demonstrated that patients with low expression of nuclear 8-OHdG had significantly longer survival time compared with those with a high expression (P=0.032), whereas cancerspecific survival of patients was not associated with hOGG1 or G6PD expression. These results suggest an involvement of oxidative DNA damage in the process of melanoma pathogenesis and demonstrate that 8-OHdG expression in nuclei of tumor cells could be useful as an early independent prognostic marker in patients with primary cutaneous
Introduction
Ultraviolet radiation-induced oxidative DNA damage is believed to be implicated in the pathogenesis of many tumors, including cutaneous melanoma (1-4). 8-hydroxy-2'-deoxyguanosine (8-OHdG) is one of the main mutagenic oxidative modifications induced in DNA and is considered a reliable marker of DNA damage induced by oxidative stress (5, 6) . The presence of 8-OHdG in DNA has a pro-mutagenic potential by mispairing with A residues, leading to an increased frequency of spontaneous G:C to T:A transversion, mutagenesis, or cell death unless correctly repaired before DNA replication (7) . This mutation is generally observed in mutated proto-oncogenes and tumor suppressor genes (8) .
Various enzymes, such as human 8-oxoguanine DNA-glycosylase 1 (hOGG1) and glucose-6-phosphate dehydrogenase (G6PD), act as protection against oxidative stress. hOGG1 is involved in the repair and prevention of 8-OHdG-derived mutations, by catalyzing the excision and removal of 8-OHdG adducts (9) and its expression may be up-regulated by the exposure to oxidative DNA damage (10) . G6PD is indispensable to reductive metabolism and maintenance of cellular redox homeostasis, being involved in the generation of NADPH required for the protection against oxidative damage (11) . 8-OHdG residues on DNA, excised by enzymatic repair systems, appear in the blood and subsequently excreted in the urine (12) . 8-OHdG level in blood and/or urine has been measured as a marker of oxidative DNA damage (13) . The finding of the 8-OHdG expression in tumor tissue directly shows the degree of oxidative damage on DNA (14, 15) . It is known that accumulation of impaired 8-OHdG could lead to increased genomic instability that in turn could lead to a more malignant phenotypic behaviour of tumors (9) . On the other hand, the low activity of enzymes, such as hOGG1 and G6PD, has been consistently associated with increased risk of progression in several tumor types (16, 17) .
Previous studies suggested an involvement of oxidative stress in the ultraviolet (UV) activation of the tumor suppressor gene p53, whose product plays an important role in the regulation of cellular response to DNA damage. In many cells, exposure to UV light leads to a dramatic increase in the cellular (19) . Survivin is a member of the inhibitor of apoptosis protein (IAP) family (20) , undetectable in most differentiated normal tissues, but strongly expressed in embryonic and fetal organs (21) . Survivin has been implicated in cell division, prevention of apoptosis, cellular stress response and checkpoint mechanisms of genomic integrity (22) . It is overexpressed in many human malignancies and such overexpression is associated with poor prognosis (23, 24) . Although survivin and p53 are both critical modulators of the opposing cellular processes of proliferation and apoptosis, there is currently no evidence of interaction between mechanisms regulating the expression of each.
Despite the numerous clinicopathological factors with prognostic value currently available, none of them can accurately predict the clinical outcome of melanoma patients. Since the malignant phenotype of tumors is sustained by the complex molecular derangement of tumor cells, the identification of novel molecular markers, sought mainly in the primary tumor and suggestive of cancer aggressiveness, could provide clinicians with novel and more effective prognostic tools (25) .
In this study, we immunohistochemically investigated the expression of 8-OHdG, hOGG1, G6PD, p53 and survivin in primary cutaneous melanoma and the relationship among these factors was analyzed. Our aim was to evaluate whether 8-OHdG, hOGG1 and G6PD expression in tumor tissues might be a predictor of survival in melanoma patients. The correlation between 8-OHdG, hOGG1 and G6PD expression and clinicopathological factors of patients was also examined. (27) , 49 tumors were stage I-II and 32 were stage III-IV. Regarding tumor thickness, 18 tumors were classified T1-T2 and 63 were T3-T4.
Materials and methods

Samples
Each tumor, after surgical resection, was fixed in formalin and completely embedded in multiple paraffin blocks. The sections taken from the block with the largest tumor thickness were evaluated. Tumoral areas were identified on haematoxylin and eosin-stained sections and on adjacent sections immunohistochemically stained for melanoma-associated antigens, including S-100 protein, melan A and HMB-45. An independent histopathological analysis was performed by two pathologists (C.F. and J.U.) on separate occasions. The study protocol was approved by the Research Ethics Committee at our institutions and informed consent was obtained from all the patients involved in the study.
Immunohistochemistry. Serial microtome sections, 5-μm thick, were treated for the immunohistochemical demonstration of 8-OHdG, hOGG1, G6PD, p53, survivin and melanomaassociated antigens S100, melan A, and HMB45 by using the alkaline phosphatase-streptavidin method.
Antigen retrieval was performed by heating at 95˚C for 40 min in 10 mM citrate buffer solution (pH 6.0), followed by gradual cooling for 20 min, for the demonstration of 8-OHdG, hOGG1, p53, survivin and melan A and by immersion in 0.1% trypsin solution in PBS at 37˚C for 5 or 10 min for G6PD or S-100 protein and the HMB-45 antigen, respectively. For the demonstration of 8-OHdG, the sections were incubated in 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 0.4 mM NaCl, 100 μg/ml RNase for 1 h at 37˚C. To denature DNA, slides were soaked in 4 N HCl for 7 min and then neutralized by incubation in 50 mM Tris-base for 5 min at room temperature. Table I . Clinicopathological characteristics of 81 cutaneous melanoma patients. 
Non-specific binding was blocked with 10% normal goat or normal horse serum for 45 min. Mouse monoclonal antibody to 8-OHdG (Trevigen, Gaithersburg, MD, USA, 1:300 dilution), to human p53 protein (clone DO-7, Dakopatts, Glostrup, Denmark, 1:50 dilution), to human melan A (clone A103, Dakopatts, 1:100 dilution), and to human HMB-45 (clone HMB-45, Dakopatts, 1:100 dilution), rabbit polyclonal antibodies to human OGG1 (Novus Biologicals, Littleton, CO, USA, 1:100 dilution), to human G6PD (Novus Biologicals, 1:100 dilution), to recombinant human survivin protein (Novus Biologicals, 1:2000 dilution), and to bovine S-100 protein (Dakopatts, 1:1000 dilution) were used as primary antisera. Biotinylated anti-mouse and anti-rabbit immunoglobulins G (Vector Laboratories, Burlingame, CA, USA, 1:800 and 1:200 dilution, respectively) were used as secondary antisera. The sections were further incubated in alkaline phosphatasestreptavidin (Vector Laboratories, 1:1000 dilution) for 30 min at room temperature, reacted with Fast Red Substrate System (Dakopatts), and counterstained with Mayer's haematoxylin.
Sections of melanoma, strongly expressing 8-OHdG and p53, were used as positive controls for 8-OHdG and p53, respectively, whereas sections of rat testis were used as positive controls for survivin, and sections of tonsil and parotid gland as positive controls for hOGG1 and G6PD staining, respectively. Negative controls were established by replacing the primary antibodies with normal serum.
Evaluation of immunoreactivity.
The entire tumor of each case was microscopically examined through x200 magnification fields with a 144-intersection point square reticulum (0.78 mm 2 ) inserted in the eyepiece, to identify and count 8-OHdG-positive cells in the nucleus, in the cytoplasm, or both, of the whole tumor and the average of these counts was considered. In the same way, adjacent sections from the same samples were evaluated for nuclear or cytoplasmic hOGG1, cytoplasmic G6PD, nuclear p53 and nuclear or cytoplasmic survivin immunoreactivity.
The results were stratified according to a staining score that took into account both percentage of positive cells and staining intensity. The samples were scored as positive for the expression of 8-OHdG, hOGG1, G6PD, p53 and survivin when >10% of tumor cells showed a moderate/strong staining intensity; otherwise, they were scored as negative.
Statistical analysis. Data were computed with the Statistical Package for the Social Sciences (SPSS) 15.0 software. The association between 8-OHdG, hOGG1, G6PD, p53 and survivin expression and the correlation of 8-OHdG, hOGG1 and G6PD expression with the clinicopathological variables of Stage I, II, III, and IV melanoma patients was assessed by Fisher's exact test or Pearson's ¯2 test. Overall survival of patients with Stage I and II melanoma was calculated from the date of histological diagnosis to the date the patients died of melanoma, or the last follow-up, until April 2008. Survival information was unavailable for one patient. Data on patients who died of other causes were censored at the time of death. Survival curves were obtained using the Kaplan-Meier method, comparisons were made using the log-rank test and were adjusted for specified prognostic factors. The 95% confidence intervals (95% CI) for survival were calculated and reported.
All tests used were two-sided. Differences were considered statistically significant at P≤0.05.
Results
Immunohistochemistry. Immunoreactivity for 8-OHdG was observed both in the nuclear and cytoplasmic compartment of tumor cells in 65% of cases, being more intense in the nucleus. 8-OHdG-positive tumor cells were spread throughout the tumoral area. Cytoplasmic immunoreaction was localized in a small amount of tumor cells with respect to nuclear staining ( Fig. 1A and B) . p53 expression, restricted to the nuclei of tumor cells, was found in 64% of samples and, in most cases, the staining intensity was from moderate to strong. p53-positive cells were observable throughout the tumor and in the basal epidermal layers ( Fig. 2A and B) .
Survivin immunoreaction was detected both in nucleus and cytoplasm in 47% of cases, exclusively in nuclei in 19% of cases. Survivin-positive cells were distributed homogeneously throughout the tumor of some cases, while others showed heterogeneous staining pattern with positive and negative cells side by side. Staining intensity was different between nuclear and cytoplasmic compartment, being more intense in the nucleus. Mitotic figures were also intensely stained, being survivin localized to mitotic spindles and chromosomes. Epidermis surrounding the tumor showed survivin cytoplasmic staining in all layers but basal layers also showed nuclear staining with higher intensity than cytoplasm (Fig. 2C and D) . In most samples, the distribution of p53 and survivinpositive cells was similar to that of 8-OHdG-stained cells.
Regarding protection factors against oxidative stress, we obtained the following results: 24% of samples showed an intense immunoreactivity for hOGG1 in the cytoplasm of tumor cells and in scattered nuclei. hOGG1-positive tumor cells were distributed throughout all the tumor and showed either a homogeneous or a fine granular staining pattern both in the nucleus and the cytoplasm (Fig. 3A) . A positive staining for hOGG1 in tumor cells was more frequent in cases positive for 8-OHdG.
G6PD immunoreaction, restricted to the cytoplasm of tumor cells, was found in 24% of cases, with positive cells distributed throughout all the tumor. Some cases demonstrated homogeneous staining intensity in the cytoplasmic compartment of tumor cells, while in others a heterogeneous staining pattern was found with some cells showing a stronger intensity than others (Fig. 3B) .
Statistical analysis. Positive immunoreactivity for 8-OHdG in nuclei of tumor cells was more frequent in cases positive for p53 and nuclear survivin, even though the difference was not statistically significant. However, when nuclear and cytoplasmic 8-OHdG staining were evaluated in combination, total 8-OHdG resulted significantly associated with p53 (P=0.026) and with nuclear or total (nuclear and cytoplasmic staining evaluated in combination) survivin immunoreactivity, with borderline significance (P=0.095). There seemed to be no correlation between cytoplasmic survivin and p53 or 8-OHdG (P>0.05). A significant association was found between p53 and survivin expression, both when nuclear and total survivin was evaluated (P<0.0001).
hOGG1-positive tumor cells were more frequent in cases positive for 8-OHdG and when analyzed by Fisher's exact test, total hOGG1 correlated with total 8-OHdG expression (P=0.009). Cases positive for total 8-OHdG were often negative for G6PD, even though the difference was not significant (P>0.05), while the absence of total hOGG1 immunoreactivity was significantly associated with the negativity for G6PD (P=0.005). Total 8-OHdG expression in relation to p53, nuclear survivin, total hOGG1 and G6PD is presented in Table II . Despite the lack of statistical significance, there was a tendency that nuclear hOGG1-negative cells were positive for p53.
In survival analysis, Kaplan-Meier univariate analysis demonstrated that patients with tumors negative for nuclear 8-OHdG had significantly longer survival time compared with those with nuclear 8-OHdG-positive tumors (P=0.032; Fig. 4) . The Kaplan-Meier estimates of overall survival probabilities at 60 months were 1 for the patients with absence of nuclear 8-OHdG expression and 0.68 (95% CI: 0.44-0.92) for those with nuclear 8-OHdG-positive tumors (Table III) .
The multivariate analysis demonstrated that the predictive value of nuclear 8-OHdG expression maintained the significance after adjusting the model by clinicopathological factors, such as tumor thickness (P=0.030), Clark level (P=0.053) and AJCC stage (P=0.039). On the contrary, cancerspecific survival of patients seemed not to be associated with hOGG1 or G6PD expression.
In correlation analysis, we did not observe a statistically significant association between 8-OHdG, hOGG1 and G6PD expression and clinicopathological factors, such as gender, age, tumor thickness, Clark level, stage and anatomic site (P>0.05). Table II . 8-OHdG expression in relation to p53, survivin, hOGG1 and G6PD. ------------------------------------------------ Table III . Univariate analysis of 8-OHdG expression for 5-year survival in melanoma patients. 
a Standard error and b log-rank test.
-
Discussion
UV radiation (UVR) is the only environmental carcinogen known to affect the risk of developing melanoma (28, 29) . The biological effects of UVR span from DNA damage to cell signaling, to metabolism, to immune response (30) . The 8-OHdG lesion, a sensitive marker of oxidative DNA damage, is suspected to be involved in the photocarcinogenic process initiated by sunlight (2) .
In vitro studies have demonstrated that 8-OHdG accumulates in cellular DNA and causes mispairing, suggesting that this oxidative modification is mutagenic and carcinogenic (31) . Elevated levels of 8-OHdG have been linked to increased risk of breast, bladder, basal cell cancers (32) (33) (34) and have been regarded as an independent prognostic factor in different types of cancer (9, 14) .
According with these studies, we found that positive immunoreactivity for 8-OHdG in nuclei of melanoma cells is significantly associated with poor overall survival and might be useful as a predictor of clinical outcome in melanoma patients. The immunoreactivity for 8-OHdG in the cytoplasm of tumor cells and epithelium was considered to reflect oxidative damage to mitochondrial DNA; however, it is clear that this widespread mitochondrial damage was unimportant with regard to melanoma progression.
Our results also showed that total 8-OHdG immunostaining is significantly associated with p53 expression, that is consistent with previous findings on tissues exposed to oxidative stress-inducing factors, that provide evidence of the concomitant presence of high expression of 8-OHdG and overexpression of p53 (35) . UV radiation, in addition to inducing oxidative DNA damage, detectable by an increase of 8-OHdG expression in cells nuclei, can also cause mutations in genes such as p53 that, when inactivated through mutation and loss of heterozygosity, can lead to cell proliferation and genomic instability (36) . Moreover, G:C to T:A transversions, induced by the presence of 8-OHdG during DNA replication, has been found in the p53 gene in human skin cancers of sun-exposed areas and in UV-induced mouse skin cancers (37) . Such mutations are believed to lead to an increased stability of this protein, allowing its more pronounced immunohistochemical detection. It is known that UV irradiation of mammalian cells leads to an increase in detectable p53 protein in the nucleus. Therefore, the study of both DNA damage induction and p53 status is a very informative way to evaluate the intensity of a given photogenotoxic stress (38) .
Our results also showed a significant correlation between the expression of p53 and nuclear survivin, supporting previous findings that suggest p53 as a transcription inhibitor factor of survivin and the functional loss of wild-type p53, for UVinduced gene alterations, as the possible mechanism responsible for survivin overexpression in melanoma (39) . The present study suggests that oxidative DNA damage, p53 functional loss, and survivin overexpression may all be involved in the process of melanoma pathogenesis.
One of the main DNA repair mechanisms involved in fixing UVR-mediated DNA damage is base excision repair (BER) and hOGG1 is the enzyme involved in the excision and removal of 8-OHdG adducts. From our data, the immunohistochemical expression of hOGG1 and G6PD, an other enzyme involved in protection against oxidative damage, did not show a significant correlation with survival in melanoma patients.
Immunopositivity for total hOGG1 in tumor cells was significantly associated with total 8-OHdG expression, indicating that hOGG1 expression may be interpreted as a biomarker of exposure to oxidative DNA damage with induction of new enzyme synthesis, as suggested by previous studies, rather than a marker of inborn DNA repair capacity (10) .
Cases positive for total 8-OHdG were often negative for G6PD, even though the difference was not significant. The absence of total hOGG1 immunoreactivity was significantly associated with the negativity for G6PD. These results could indicate an imbalance in the independent repair mechanisms of hOGG1 and G6PD in the presence of oxidative stress in melanoma cells, even though further studies are required to clarify the function of these enzymes against oxidative damage. Despite the lack of statistical significance, there was a tendency that nuclear hOGG1-negative cells were positive for p53. This result is in agreement with previous findings indicating that loss of p53 function, consistent with its immunohistochemical overexpression, can lead to decreased hOGG1 expression (40) . However, the precise mechanism by which p53 may regulate hOGG1 expression is still under investigation.
In conclusion, because of the importance to identify novel molecular prognostic indicators for melanoma patients, the present study suggests that patients with tumors positive for nuclear 8-OHdG expression should be regarded as being at high risk of mortality and that nuclear 8-OHdG could be useful as an early independent prognostic factor in patients with primary cutaneous melanoma, in association with the other prognostic markers currently in use. This could be regarded in the prevention of melanoma development by avoiding exposure to UV light, capable of inducing oxidative DNA modifications responsible for melanoma pathogenesis. On the other hand, the evaluation of 8-OHdG in tumor cells might aid patient selection for adjuvant therapies and represent a valid target for treatment.
